Biomerica
BMRA
20 hedge funds and large institutions have $220K invested in Biomerica in 2026 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
82% more funds holding
Funds holding: 11 → 20 (+9)
0.35% more ownership
Funds ownership: 3.7% → 4.05% (+0.35%)
7% less capital invested
Capital invested by funds: $236K → $220K (-$16.1K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$56.6K |
| 2 |
Jane Street
New York
|
+$27.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$511 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$178 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$68K |
| 2 |
HCM
Hollencrest Capital Management
Newport Beach,
California
|
-$1.34K |
BMRA Hedge Fund Activity: Q2 2026 in Review
20 of the 8,330 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q2 2026, worth a combined $220K — down 6.8% from $236K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BMRA positions and 0 closed out — a net gain of 9 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $56.6K. The largest seller was Geode Capital Management, cutting an estimated $68K.
- 20 institutional investors held Biomerica (BMRA) as of Q2 2026, up from 11 in Q1 2026.
- Funds reported $220K of Biomerica stock for Q2 2026, down 6.8% quarter-over-quarter.
- 9 funds opened new Biomerica positions in Q2 2026 and 0 closed out, a net change of +9 holders.
- The largest Biomerica buyer in Q2 2026 was HRT Financial, an estimated $56.6K added.
- The largest Biomerica seller in Q2 2026 was Geode Capital Management, an estimated $68K sold.
Based on aggregated 13F filings for Q2 2026.